Role of janus kinase 3 in predisposition to obesity-associated metabolic syndrome

Journal of Biological Chemistry

Volumn 290, Issue 49, 2015, Pages 29301-29312

  Mishra, Jayshree ^a   Verma, Raj K ^a   Alpini, Gianfranco ^b   Meng, Fanyin ^b   Kumar, Narendra ^a  

^a TEXAS A AND M UNIVERSITY SYSTEM   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHEMICAL ACTIVATION; HEALTH RISKS; NUTRITION;

HEALTH COMPLICATIONS; INSULIN RECEPTORS; INTESTINAL EPITHELIAL CELLS; INTESTINAL MUCOSA; METABOLIC SYNDROMES; REGULATORY SUBUNITS; TOLL-LIKE RECEPTORS; TYROSINE PHOSPHORYLATION;

METABOLISM;

GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; JANUS KINASE 3; MYELOPEROXIDASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; TOLL LIKE RECEPTOR; CYTOKINE; INSULIN; JAK3 PROTEIN, HUMAN; JAK3 PROTEIN, MOUSE; PIPERIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; TOFACITINIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; EPIDIDYMIS FAT; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HISTOLOGY; HUMAN; HUMAN CELL; HYPERINSULINEMIA; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; INSULIN TOLERANCE TEST; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; LIPID DIET; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WEIGHT GAIN; WESTERN BLOTTING; WESTERN DIET; ANIMAL; BLOOD; C57BL MOUSE; CACO-2 CELL LINE; CHEMISTRY; DISEASE MODEL; FLUORESCENCE MICROSCOPY; GENETIC PREDISPOSITION; GENETICS; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; BODY WEIGHT; CACO-2 CELLS; CYTOKINES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TOLERANCE TEST; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INSULIN; JANUS KINASE 3; LIVER; MALE; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; OBESITY; ORGAN SIZE; PIPERIDINES; PYRIMIDINES; PYRROLES; RISK FACTORS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84949032177     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.670331     Document Type: Article

References (61)

1. Bleau, C., Karelis, A. D., St-Pierre, D. H., and Lamontagne, L. (2014) Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes. Diabetes Metab. Res. Rev. 31, 545-561
2. Kanneganti, T. D., and Dixit, V. D. (2012) Immunological complications of obesity. Nat. Immunol. 13, 707-712
3. Nunemaker, C. S., Chen, M., Pei, H., Kimble, S. D., Keller, S. R., Carter, J. D., Yang, Z., Smith, K. M., Wu, R., Bevard, M. H., Garmey, J. C., and Nadler, J. L. (2008) 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet. Am. J. Physiol. Endocrinol. Metab. 295, E1065-E1075
4. Reilly, S. M., Chiang, S. H., Decker, S. J., Chang, L., Uhm, M., Larsen, M. J., Rubin, J. R., Mowers, J., White, N. M., Hochberg, I., Downes, M., Yu, R. T., Liddle, C., Evans, R. M., Oh, D., Li, P., Olefsky, J. M., and Saltiel, A. R. (2013) An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice. Nat. Med. 19, 313-321
5. Crunkhorn, S. (2013) Metabolic disorders: Breaking the links between inflammation and diabetes. Nat. Rev. Drug Discov. 12, 261
6. Onat, A., Can, G., Hergenç, G., Yazici, M., Karabulut, A., and Albayrak, S. (2007) Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int. J. Obes. 31, 1119-1125
7. Ding, S., and Lund, P. K. (2011) Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 14, 328-333
8. Phillips, C. M., and Perry, I. J. (2013) Does inflammation determine metabolic health status in obese and nonobese adults? J. Clin. Endocrinol. Metab. 98, E1610-E1619
9. Wildman, R. P., Muntner, P., Reynolds, K., McGinn, A. P., Rajpathak, S., Wylie-Rosett, J., and Sowers, M. R. (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch. Intern. Med. 168, 1617-1624
10. Lucas, K., and Maes, M. (2013) Role of the toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol. Neurobiol. 48, 190-204
11. Wang, H., Brown, J., Gao, S., Liang, S., Jotwani, R., Zhou, H., Suttles, J., Scott, D. A., and Lamont, R. J. (2013) The role of JAK-3 in regulating TLR-mediated inflammatory cytokine production in innate immune cells. J. Immunol. 191, 1164-1174
12. Könner, A. C., and Brüning, J. C. (2011) Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol. Metab. 22, 16-23
13. Fresno, M., Alvarez, R., and Cuesta, N. (2011) Toll-like receptors, inflammation, metabolism and obesity. Arch. Physiol. Biochem. 117, 151-164
14. Kawai, T., and Akira, S. (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384
15. Jialal, I., and Kaur, H. (2012) The Role of toll-like receptors in diabetesinduced inflammation: implications for vascular complications. Curr. Diab. Rep. 12, 172-179
16. Park, J. S., Seo, J. H., and Youn, H. S. (2013) Gut microbiota and clinical disease: obesity and nonalcoholic fatty liver disease. J. Pediatr. Gastroenterol. Nutr. 16, 22-27
17. Everard, A., and Cani, P. D. (2013) Diabetes, obesity and gut microbiota. Best Pract. Res. Clin. Gastroenterol. 27, 73-83
18. Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., and Bouchard, C. (1992) Genetic aspects of susceptibility to obesity and related dyslipidemias. Mol. Cell. Biochem. 113, 151-169
19. Bertrand, R. L., Senadheera, S., Markus, I., Liu, L., Howitt, L., Chen, H., Murphy, T. V., Sandow, S. L., and Bertrand, P. P. (2011) A Western diet increases serotonin availability in rat small intestine. Endocrinology 152, 36-47
20. Safford, M. G., Levenstein, M., Tsifrina, E., Amin, S., Hawkins, A. L., Griffin, C. A., Civin, C. I., and Small, D. (1997) JAK3: expression and mapping to chromosome 19p12-13.1. Exp. Hematol. 25, 374-386
21. Takahashi, T., and Shirasawa, T. (1994) Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases. FEBS Lett. 342, 124-128
22. Murata, Y., Yamashita, A., Saito, T., Sugamura, K., and Hamuro, J. (2002) The conversion of redox status of peritoneal macrophages during pathological progression of spontaneous inflammatory bowel disease in Janus family tyrosine kinase 3(-/-) and IL-2 receptor β(-/-) mice. Int. Immunol. 14, 627-636
23. Ding, S., Chi, M. M., Scull, B. P., Rigby, R., Schwerbrock, N. M., Magness, S., Jobin, C., and Lund, P. K. (2010) High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 5, e12191
24. Flint, H. J., Scott, K. P., Louis, P., and Duncan, S. H. (2012) The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 9, 577-589
25. Mishra, J., Karanki, S. S., and Kumar, N. (2012) Identification of molecular switch regulating interactions of Janus kinase 3 with cytoskeletal proteins. J. Biol. Chem. 287, 41386-41391
26. Kumar, N., Mishra, J., Narang, V. S., and Waters, C. M. (2007) Janus kinase 3 regulates interleukin 2-induced mucosal wound repair through tyrosine phosphorylation of villin. J. Biol. Chem. 282, 30341-30345
27. Mishra, J., Waters, C. M., and Kumar, N. (2012) Molecular mechanism of interleukin-2-induced mucosal homeostasis. Am. J. Physiol. Cell Physiol. 302, C735-C747
28. Mishra, J., Verma, R. K., Alpini, G., Meng, F., and Kumar, N. (2013) Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis. J. Biol. Chem. 288, 31795-31806
29. Mishra, J., Drummond, J., Quazi, S. H., Karanki, S. S., Shaw, J. J., Chen, B., and Kumar, N. (2013) Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. Crit. Rev. Oncol. Hematol. 86, 232-250
30. Kumar, N., Mishra, J., and Quazi, S. H. (2012) Training the defense system for modern-day warfare: the horizons for immunotherapy and vaccines for cancer. J. Immunodefic. Disord. 1, 1-7
31. Tilly, B. C., Kansen, M., van Gageldonk, P. G., van den Berghe, N., Galjaard, H., Bijman, J., and de Jonge, H. R. (1991) G-proteins mediate intestinal chloride channel activation. J. Biol. Chem. 266, 2036-2040
32. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., and Spiegelman, B. M. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665-668
33. Lai, K. S., Jin, Y., Graham, D. K., Witthuhn, B. A., Ihle, J. N., and Liu, E. T. (1995) A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells. J. Biol. Chem. 270, 25028-25036
34. Thomis, D. C., Gurniak, C. B., Tivol, E., Sharpe, A. H., and Berg, L. J. (1995) Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270, 794-797
35. Grima, P., Guido, M., Chiavaroli, R., Stano, F., Tundo, P., Tana, M., de Donno, A., and Zizza, A. (2012) Altered phosphate metabolism in HIV-1-infected patients with metabolic syndrome. Scand. J. Infect. Dis. 44, 133-137
36. Plagemann, A., Harder, T., Brunn, M., Harder, A., Roepke, K., Wittrock-Staar, M., Ziska, T., Schellong, K., Rodekamp, E., Melchior, K., and Dudenhausen, J. W. (2009) Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome. J. Physiol. 587, 4963-4976
37. Maziak, W. (2005) The asthma epidemic and our artificial habitats. BMC Pulm. Med. 5, 5
38. Stempel, D. A. (2005) September epidemic of asthma exacerbations in children: a manifestation of persistent or episodic disease? J. Allergy Clin. Immunol. 115, 230-232
39. Phillips, C. M., Goumidi, L., Bertrais, S., Field, M. R., McManus, R., Hercberg, S., Lairon, D., Planells, R., and Roche, H. M. (2012) Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome. J. Nutr. Biochem. 23, 239-244
40. Cuda, C., Badawi, A., Karmali, M., and El-Sohemy, A. (2011) Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol. Metabolism 60, 1131-1135
41. Tulk, H. M., and Robinson, L. E. (2009) Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome. Metabolism 58, 1709-1716
42. Kim, J. J., and Sears, D. D. (2010) TLR4 and insulin resistance. Gastroenterol. Res. Pract. 2010, 1-11
43. Ubeda, C., Lipuma, L., Gobourne, A., Viale, A., Leiner, I., Equinda, M., Khanin, R., and Pamer, E. G. (2012) Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J. Exp. Med. 209, 1445-1456
44. Chassaing, B., and Gewirtz, A. T. (2014) Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol. Pathol. 42, 49-53
45. Chassaing, B., Ley, R. E., and Gewirtz, A. T. (2014) Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent lowgrade inflammation and metabolic syndrome in mice. Gastroenterology 147, 1363-1377.e17
46. Esteve, E., Ricart, W., and Fernández-Real, J. M. (2011) Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? Curr. Opin. Clin. Nutr. Metab. Care 14, 483-490
47. Arslan, N. (2014) Obesity, fatty liver disease and intestinal microbiota. World J. Gastroenterol. 20, 16452-16463
48. Guarner, V., and Rubio-Ruiz, M. E. (2015) Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease. Interdiscip. Top. Gerontol. 40, 99-106
49. Kim, F., Pham, M., Maloney, E., Rizzo, N. O., Morton, G. J., Wisse, B. E., Kirk, E. A., Chait, A., and Schwartz, M. W. (2008) Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler. Thromb. Vasc. Biol. 28, 1982-1988
50. de Wit, N. J., Bosch-Vermeulen, H., de Groot, P. J., Hooiveld, G. J., Bromhaar, M. M., Jansen, J., Müller, M., and van der Meer, R. (2008) The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice. BMC Med. Genomics 1, 14
51. Yan, Z. Q. (2006) Regulation of TLR4 expression is a tale about tail. Arterioscler. Thromb. Vasc. Biol. 26, 2582-2584
52. Takahashi, K., Sugi, Y., Hosono, A., and Kaminogawa, S. (2009) Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J. Immunol. 183, 6522-6529
53. Stadnyk, A. W. (2002) Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can. J. Gastroenterol. 16, 241-246
54. Malaviya, R., Zhu, D., Dibirdik, I., and Uckun, F. M. (1999) Targeting Janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis. J. Biol. Chem. 274, 27028-27038
55. Tortolani, P. J., Lal, B. K., Riva, A., Johnston, J. A., Chen, Y. Q., Reaman, G. H., Beckwith, M., Longo, D., Ortaldo, J. R., Bhatia, K., McGrath, I., Kehrl, J., Tuscano, J., McVicar, D. W., and O'Shea, J. J. (1995) Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J. Immunol. 155, 5220-5226
56. Ward, A. C., Touw, I., and Yoshimura, A. (2000) The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood 95, 19-29
57. Hall, B. M. (1991) Cells mediating allograft rejection. Transplantation 51, 1141-1151
58. Stepkowski, S. M., Erwin-Cohen, R. A., Behbod, F., Wang, M. E., Qu, X., Tejpal, N., Nagy, Z. S., Kahan, B. D., and Kirken, R. A. (2002) Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin. Blood 99, 680-689
59. Säemann, M. D., Diakos, C., Kelemen, P., Kriehuber, E., Zeyda, M., Böhmig, G. A., Hörl, W. H., Baumruker, T., and Zlabinger, G. J. (2003) Prevention of CD40-triggered dendritic cell maturation and induction of Tcell hyporeactivity by targeting of Janus kinase 3. Am. J. Transplant. 3, 1341-1349
60. Cetkovic-Cvrlje, M., and Tibbles, H. E. (2004) Therapeutic potential of Janus kinase 3 (JAK3) inhibitors. Curr. Pharm. Des. 10, 1767-1784
61. Mishra, J., and Kumar, N. (2014) Adapter protein Shc regulates Janus kinase 3 phosphorylation. J. Biol. Chem. 289, 15951-15956